Skip to main content

Home/ Nutrition/ Group items tagged intravenous

Rss Feed Group items tagged

Matti Narkia

The controversial place of vitamin C in cancer treatment - ScienceDirect - Biochemical ... - 0 views

  •  
    The controversial place of vitamin C in cancer treatment.
    Verrax J, Calderon PB.
    Biochem Pharmacol. 2008 Dec 15;76(12):1644-52. Epub 2008 Sep 30. Review.
    PMID: 18938145
    doi:10.1016/j.bcp.2008.09.024    
Matti Narkia

A pilot clinical study of continuous intravenous a...[P R Health Sci J. 2005] - PubMed ... - 0 views

  •  
    A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
    Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA.
    P R Health Sci J. 2005 Dec;24(4):269-76.
    PMID: 16570523
Matti Narkia

Changes of terminal cancer patients' health-related quality of life after high dose vit... - 0 views

  •  
    Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration.\nYeom CH, Jung GC, Song KJ.\nJ Korean Med Sci. 2007 Feb;22(1):7-11.\nPMID: 17297243
Matti Narkia

Intravenous vitamin C as a chemotherapy agent: a r...[P R Health Sci J. 2004] - PubMed ... - 0 views

  •  
    Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.\nRiordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.\nP R Health Sci J. 2004 Jun;23(2):115-8.\nPMID: 15377059
Matti Narkia

Intravenously administered vitamin C as cancer therapy: three cases. - CMAJ. 2006 Mar 28 - 0 views

  •  
    Intravenously administered vitamin C as cancer therapy: three cases.\nPadayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M.\nCMAJ. 2006 Mar 28;174(7):937-42.\nPMID: 16567755 \ndoi:10.1503/cmaj.050346.
Matti Narkia

Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and h... - 0 views

  •  
    Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo.\nChen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR, Levine M.\nProc Natl Acad Sci U S A. 2007 May 22;104(21):8749-54. Epub 2007 May 14.\nPMID: 17502596 \n doi: 10.1073/pnas.0702854104\n
Matti Narkia

Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. - Ann Oncol. 2008 ... - 0 views

  •  
    Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.
    Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, Rousseau C, Robitaille L, Miller WH Jr.
    Ann Oncol. 2008 Nov;19(11):1969-74. Epub 2008 Jun 9. Erratum in: Ann Oncol. 2008 Dec;19(12):2095.
    PMID: 18544557
    doi:10.1093/annonc/mdn377
Matti Narkia

Vitamin C and cancer revisited - PNAS - 0 views

  •  
    Vitamin C and cancer revisited.
    Frei B, Lawson S.
    Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11037-8. Epub 2008 Aug 5.
    PMID: 18682554
Matti Narkia

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive ... - 0 views

  •  
    Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.
    Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M.
    Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9. Epub 2008 Aug 4.
    PMID: 18678913
    doi: 10.1073/pnas.0804226105
1 - 9 of 9
Showing 20 items per page